Arthur Levine, Chief Financial Officer at Sensus Healthcare, Inc. (SRTS), sold 110 shares at $6.00 ($660) on 2017-09-13, disclosed to the SEC on 2017-09-19.
Scheduled sale ($660) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SRTS | SELL | 2018-08-10 | $3K | — | Filing → |
| SRTS | SELL | 2018-08-06 | $150 | — | Filing → |
| SRTS | SELL | 2018-06-28 | $330 | — | Filing → |